On 15–16 July 2019, WHO organized a consultation to review the state-of-the-art in malaria vaccine R&D. The aims of this consultation were:
- to provide a landscape status of malaria vaccine R&D;
- to discuss potential malaria vaccine use cases, taking into account recent changes and the heterogeneity of malaria epidemiology;
- to consider key product profile attributes and programmatic suitability;
- to discuss early and late development data packages for decision-making challenges and opportunities in malaria vaccine evaluation pathways.